Viewing Study NCT02890069


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2026-01-03 @ 1:45 AM
Study NCT ID: NCT02890069
Status: COMPLETED
Last Update Posted: 2023-01-11
First Post: 2016-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module